Compare stocks

Bonesupport Holding AB, founded in 1999 and headquartered in Lund, Sweden, specializes in developing and commercializing injectable bio-ceramic bone graft substitutes under the CERAMENT® brand. These products are designed to remodel into the patient's own bone and can elute drugs directly into bone voids. The company's portfolio includes CERAMENT® Bone Void Filler, CERAMENT® G, and CERAMENT® V, targeting conditions such as bone voids resulting from trauma, infection, or disease. In 2024, Bonesupport reported net sales of SEK 898.7 million, marking a 52% increase from the previous year. The company operates in Europe, North America, and other international markets, focusing on orthobiologics for bone injury management.

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.